Compound_ID |
Target |
Gene_Name |
Gene_ID |
Cancer |
Cell_lines |
IC50 Value |
EC50 Value |
ED50 Value |
GI50 Value |
Remarks |
References |
MMP-AC0180 |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
836 |
Bladder Cancer |
T24 |
- |
- |
- |
- |
The data also indicated that activation of caspase-3 contributed to ellagic acid-induced apoptosis in T24 cells. |
15868936 |
MMP-AC0180 |
CDK2 |
Cyclin-dependent kinase 2 |
1017 |
Bladder Cancer |
T24 |
- |
- |
- |
- |
The data demonstrated that 1-50 µM ellagic acid increased p53 and p21 levels and decreased CDK2 levels. These effects of ellagic acid on p53, p21 and CDK2 were also dose-dependent. |
15868936 |
MMP-AC0180 |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
1026 |
Cervical Cancer |
CaSki |
- |
- |
- |
- |
Ellagic acid induce an increase in the expression of both p21 mRNA and protein. |
10355751 |
MMP-AC0180 |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
1026 |
Bladder Cancer |
T24 |
- |
- |
- |
- |
The data demonstrated that 1-50 µM ellagic acid increased p53 and p21 levels and decreased CDK2 levels. These effects of ellagic acid on p53, p21 and CDK2 were also dose-dependent. |
15868936 |
MMP-AC0180 |
TP53 |
tumor protein p53 |
7157 |
Bladder Cancer |
T24 |
- |
- |
- |
- |
The data demonstrated that 1-50 µM ellagic acid increased p53 and p21 levels and decreased CDK2 levels. These effects of ellagic acid on p53, p21 and CDK2 were also dose-dependen. |
15868936 |